Floatz logo

Therapeutic Asset Ratings

427 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tamsulosin
Prostate Cancer
Turku University HospitalP4BB (64)
CTT-1057
Prostate Cancer
Novartis PharmaceuticalsP3BB (64)
CYPROTERONE
Prostate Cancer
BayerP3BB (64)
FCH
Prostate Cancer
ITEL Telecomunicazioni SrlP3BB (64)
Histrelin
Prostate Cancer
Mayo ClinicP3BB (64)
Fluciclovine
Prostate Cancer
Blue Earth DiagnosticsP4B (63)
PIFLUFOLASTAT
Prostate Cancer
Novartis PharmaceuticalsP4B (63)
Rocuronium
Prostate Cancer
Memorial Sloan Kettering Cancer CenterP4B (63)
VIPIVOTIDE TETRAXETAN
Prostate Cancer
Mayo ClinicP4B (63)
TAMOXIFEN
Prostate Cancer
University Health Network, TorontoP3B (63)
Ptvg-Hp
Prostate Cancer
University of Wisconsin, MadisonP2B (63)
ROSOPATAMAB
Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty LimitedP2B (63)
LIDOCAINE
Prostate Cancer
University of WashingtonP4B (62)
Cyclophosphamide
Prostate Cancer
Icahn School of Medicine at Mount SinaiP3B (62)
Epirubicin
Prostate Cancer
Icahn School of Medicine at Mount SinaiP3B (62)
Inno-206
Prostate Cancer
University of California, San FranciscoP3B (62)
Irinotecan
Prostate Cancer
Fred Hutchinson Cancer CenterP3B (62)
Pembrolizumab
Prostate Cancer
Icahn School of Medicine at Mount SinaiP3B (62)
(+)-VINCRISTINE
Prostate Cancer
Fred Hutchinson Cancer CenterP3B (62)
Benadryl
Prostate Cancer
Merck Sharp & Dohme LLCP4B (61)
Metformin
Prostate Cancer
University of ArkansasP4B (61)
TESTOSTERONE CIPIONATE
Prostate Cancer
University of MiamiP4B (61)
TESTOSTERONE UNDECYLATE
Prostate Cancer
Roswell Park Cancer InstituteP4B (61)
Apalutamide
Prostate Cancer
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARDP3B (61)
Capivasertib
Prostate Cancer
VA Office of Research and DevelopmentP3B (61)
Showing 26 to 50 of 427 assets
PreviousPage 2 of 18Next